切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2026, Vol. 15 ›› Issue (03) : 426 -432. doi: 10.3877/cma.j.issn.2095-3232.2026.03.019

综述

IL-23/IL-17轴在棘球蚴病中的研究进展
何荣东1,2, 吐尔洪江·吐逊1,2, 温浩1,2,()   
  1. 1 830054 乌鲁木齐,新疆医科大学第一附属医院肝脏·腹腔镜外科
    2 830054 乌鲁木齐,新疆医科大学省部共建中亚高发病成因与防治国家重点实验室
  • 收稿日期:2025-11-12 出版日期:2026-06-10
  • 通信作者: 温浩
  • 基金资助:
    国家自然科学基金(82270632,82260411); 新疆医科大学国家级高层次人才培育项目(XYD2024GR08); 新疆维吾尔自治区“天山英才”培养计划青年拔尖人才项目(2024TSYCCX0105); 新疆维吾尔自治区重点研发项目(2022B03013-3)

Research progress in IL-23/IL-17 axis in echinococcosis

Rongdong He1,2, ·Tuxun Tuerhongjiang1,2, Hao Wen1,2,()   

  1. 1 Department of Liver and Laparoscopic Surgery, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
    2 State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi 830054, China
  • Received:2025-11-12 Published:2026-06-10
  • Corresponding author: Hao Wen
引用本文:

何荣东, 吐尔洪江·吐逊, 温浩. IL-23/IL-17轴在棘球蚴病中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(03): 426-432.

Rongdong He, ·Tuxun Tuerhongjiang, Hao Wen. Research progress in IL-23/IL-17 axis in echinococcosis[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(03): 426-432.

棘球蚴病是一种广泛分布的人畜共患疾病,其发病隐匿,潜伏期长,严重威胁人类健康。其免疫逃逸与宿主免疫系统相互作用复杂,特别是辅助性T(Th)细胞亚群及其分泌的细胞因子在疾病进展中起关键作用。本文综述IL-23/IL-17轴在棘球蚴病中的作用。IL-23由活化的树突状细胞和巨噬细胞分泌,可促进Th17细胞分化并分泌IL-17。研究表明,在细粒棘球蚴病中,IL-23和IL-17水平变化与感染阶段和免疫反应密切相关,且受药物干预影响;在多房棘球蚴病中,IL-23和IL-17在感染早期上升,晚期与疾病活动性相关。IL-23/IL-17轴通过JAK/STAT信号通路调节炎症反应和免疫细胞功能,在棘球蚴病的免疫调节中发挥重要作用。进一步研究该轴在棘球蚴病中的作用机制,有助于开发新的治疗靶点和生物标志物,为棘球蚴病的早期诊断、预后评估和免疫治疗提供新思路。

Echinococcosis is a zoonotic parasitic disease that is distributed widely around the world, with hidden onset and long incubation period, which seriously threatens human health. The interaction between immune escape and host immune system is complex, and especially the helper T(Th) cell subsets and their secreted cytokines play a key role in disease progression. In this article, the role of IL-23/IL-17 axis in echinococcosis was reviewed. IL-23 is secreted by activated dendritic cells and macrophages, which can promote the differentiation of Th17 cells and secrete IL-17. Studies have shown that the changes of IL-23 and IL-17 levels in cystic echinococcosis are closely associated with the infection stage and immune response, and affected by drug intervention. In alveolar echinococcosis, IL-23 and IL-17 levels are increased in the early stage of infection, and are associated with disease activity in the late stage. IL-23/IL-17 axis can regulate inflammatory response and immune cell function through the JAK/STAT signaling pathway, which plays an important role in immune regulation of echinococcosis. Further study of the mechanism underlying IL-23/IL-17 axis in echinococcosis will contribute to developing novel therapeutic targets and biomarkers, providing new ideas for early diagnosis, prognostic evaluation and immunotherapy of echinococcosis.

图1 IL-23相关重要发现时间轴
图2 IL-23/IL-17轴受体及信号通路 注:巨噬细胞和树突状细胞分泌IL-23,与细胞膜上IL-23R结合,经过JAK/STAT信号通路影响Th17细胞分泌IL-17A~F作用于棘球蚴病;Macrophages为巨噬细胞,Dendritic cells为树突状细胞,Echinococcosis为棘球蚴病
[1]
祖米来提·波拉提, 胡雪源, 郭强, 等. 肝细粒棘球蚴病胆道并发症的研究进展[J/OL]. 中华普通外科学文献(电子版), 2025, 19(2): 119-123. DOI: 10.3877/cma.j.issn.1674-0793.2025.02.010.
[2]
Yang X, Wang Q, Shao F, et al. Cell volume regulation modulates macrophage-related inflammatory responses via JAK/STAT signaling pathways[J]. Acta Biomater, 2024, 186: 286-299. DOI: 10.1016/j.actbio.2024.07.046.
[3]
Yasen A, Li W, Ran B, et al. Identification of infiltrating immune cell subsets and heterogeneous macrophages in the lesion microenvironment of hepatic cystic echinococcosis patients with different cyst viability[J]. Acta Trop, 2021, 221: 106029. DOI: 10.1016/j.actatropica.2021.106029.
[4]
Wang H, Li Y, Yu Q, et al. Immunological characteristics of hepatic dendritic cells in patients and mouse model with liver Echinococcus multilocularis infection[J]. Trop Med Infect Dis, 2024, 9(5): 95. DOI: 10.3390/tropicalmed9050095.
[5]
Wang L, Wu K, Li L, et al. Regulation of host regulatory T cell differentiation by emu-let-7-5p in Echinococcus multilocularis infection through targeting NFκB2[J]. FASEB J, 2025, 39(9): e70603. DOI: 10.1096/fj.202403437R.
[6]
Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12[J]. Immunity, 2000, 13(5): 715-725. DOI: 10.1016/s1074-7613(00)00070-4.
[7]
Bloch Y, Felix J, Merceron R, et al. Structures of complete extracellular receptor assemblies mediated by IL-12 and IL-23[J]. Nat Struct Mol Biol, 2024, 31(4): 591-597. DOI: 10.1038/s41594-023-01190-6.
[8]
D’Haens G, Panaccione R, Baert F, et al. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials[J]. Lancet, 2022, 399(10340): 2015-2030. DOI: 10.1016/S0140-6736(22)00467-6.
[9]
Risankizumab induction therapy in patients with moderately to severely active ulcerative colitis: efficacy and safety in the randomized phase 3 INSPIRE study[J]. Gastroenterol Hepatol, 2023, 19(12 Suppl 9): 9-10.
[10]
Zhou JR, Du XX, Abulajiang X, et al. The role of memory T cells in Echinococcus granulosus-induced sensitization[J]. Immun Inflamm Dis, 2023, 11(8): e948. DOI: 10.1002/iid3.948.
[11]
Nicolao MC, Rodrigues CR, Coccimiglio MB, et al. Characterization of protein cargo of Echinococcus granulosus extracellular vesicles in drug response and its influence on immune response[J]. Parasit Vectors, 2023, 16(1): 255. DOI: 10.1186/s13071-023-05854-6.
[12]
Wang M, Qiao F, Li Z, et al. Impact of Echinococcus granulosus antigens on monocyte development and dendritic cell differentiation[J]. Iran J Immunol, 2023, 20(3): 348-358. DOI: 10.22034/iji.2023.98163.2557.
[13]
Wu J, Ma HZ, Apaer S, et al. Impact of albendazole on cytokine and chemokine response profiles in Echinococcus multilocularis-inoculated mice[J]. Biomed Res Int, 2021, 2021: 6628814. DOI: 10.1155/2021/6628814.
[14]
Dabbaghizadeh A, Dion J, Maali Y, et al. Novel RORγt inverse agonists limit IL-17-mediated liver inflammation and fibrosis[J]. J Immunol, 2025, 214(6): 1321-1331. DOI: 10.1093/jimmun/vkaf014.
[15]
Kaur P, Prabhahar A, Pal D, et al. IL-23/IL-17 in a paradoxical association with primary membranous nephropathy[J]. Inflammation, 2024, 47(4): 1536-1544. DOI: 10.1007/s10753-024-01992-w.
[16]
Askoura M, Abbas HA, Al Sadoun H, et al. Elevated levels of IL-33, IL-17 and IL-25 indicate the progression from chronicity to hepatocellular carcinoma in hepatitis C virus patients[J]. Pathogens, 2022, 11(1): 57. DOI: 10.3390/pathogens11010057.
[17]
Al-Masoudi HK, Al-Hamadani KC, Khiarull IA. Interleukin 17 cytokine profiles in patients with cystic echinococcosis in Babylon province, Iraq[J]. Arch Razi Inst, 2021, 76(5): 1493-1500. DOI: 10.22092/ari.2021.355855.1730.
[18]
Yang J, Zhao Y, Fu Y, et al. Recombinant antigen P29 of Echinococcus granulosus induces Th1, Tc1, and Th17 cell immune responses in sheep[J]. Front Immunol, 2023, 14: 1243204. DOI: 10.3389/fimmu.2023.1243204.
[19]
Yasen A, Li W, Aini A, et al. Th1/Th2/Th17 cytokine profile in hepatic cystic Echinococcosis patients with different cyst stages[J]. Parasite Immunol, 2021, 43(7): e12839. DOI: 10.1111/pim.12839.
[20]
Hou X, Shi Y, Kang X, et al. Echinococcus granulosus: the establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model[J]. Front Cell Infect Microbiol, 2022, 12: 983119. DOI: 10.3389/fcimb.2022.983119.
[21]
Yang S, Du X, Wang C, et al. Coding and noncoding RNA expression profiles of spleen CD4+ T lymphocytes in mice with echinococcosis[J]. Contrast Media Mol Imaging, 2022, 2022: 9742461. DOI: 10.1155/2022/9742461.
[22]
Ghabdian S, Parande Shirvan S, Maleki M, et al. Exacerbation of allergic asthma by somatic antigen of Echinococcus granulosus in allergic airway inflammation in BALB/c mice[J]. Parasit Vectors, 2022, 15(1): 16. DOI: 10.1186/s13071-021-05125-2.
[23]
Li B, Qi X, Liu Y, et al. Monocyte-derived macrophages: the supplements of hepatic macrophage in Echinococcus multilocularis infected mice[J]. Immun Inflamm Dis, 2022, 10(10): e699. DOI: 10.1002/iid3.699.
[24]
Han S, Kim B, Hyeon DY, et al. Distinctive CD39+CD9+ lung interstitial macrophages suppress IL-23/Th17-mediated neutrophilic asthma by inhibiting NETosis[J]. Nat Commun, 2024, 15(1): 8628. DOI: 10.1038/s41467-024-53038-2.
[25]
Khan S, Bilal H, Khan MN, et al. Interleukin inhibitors and the associated risk of candidiasis[J]. Front Immunol, 2024, 15: 1372693. DOI: 10.3389/fimmu.2024.1372693.
[26]
Li H, Tsokos MG, Bhargava R, et al. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation[J]. J Clin Invest, 2021, 131(12): e142428. DOI: 10.1172/JCI142428.
[27]
Reuveni D, Brezis MR, Brazowski E, et al. Interleukin 23 produced by hepatic monocyte-derived macrophages is essential for the development of murine primary biliary cholangitis[J]. Front Immunol, 2021, 12: 718841. DOI: 10.3389/fimmu.2021.718841.
[28]
Hu X, Li J, Fu M, et al. The JAK/STAT signaling pathway: from bench to clinic[J]. Signal Transduct Target Ther, 2021, 6(1): 402. DOI: 10.1038/s41392-021-00791-1.
[29]
McInnes IB, Szekanecz Z, McGonagle D, et al. A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition[J]. Rheumatology, 2022, 61(5): 1783-1794. DOI: 10.1093/rheumatology/keab740.
[30]
Schinocca C, Rizzo C, Fasano S, et al. Role of the IL-23/IL-17 pathway in rheumatic diseases: an overview[J]. Front Immunol, 2021, 12: 637829. DOI: 10.3389/fimmu.2021.637829.
[31]
Park H, Lee S, Lee J, et al. Exploring the JAK/STAT signaling pathway in hepatocellular carcinoma: unraveling signaling complexity and therapeutic implications[J]. Int J Mol Sci, 2023, 24(18): 13764. DOI: 10.3390/ijms241813764.
[1] 郑文浩, 王海霞, 程飚. 富血小板血浆通过调控巨噬细胞极化促进创面愈合的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(02): 141-146.
[2] 谭灵屏, 余川颖, 张驰, 高雳, 赵川江. 线粒体动力学:炎症微环境中Th17/Treg细胞平衡调控机制的新视角[J/OL]. 中华口腔医学研究杂志(电子版), 2025, 19(04): 240-246.
[3] 张杰, 张志扬, 聂勇, 蒋铁民. 离体肝切除联合自体肝移植的技术创新与临床应用进展[J/OL]. 中华普通外科学文献(电子版), 2025, 19(05): 351-355.
[4] 祖米来提·波拉提, 胡雪源, 郭强, 蒋铁民. 肝细粒棘球蚴病胆道并发症的研究进展[J/OL]. 中华普通外科学文献(电子版), 2025, 19(02): 119-123.
[5] 刘小丽, 罗倩, 种玉婷, 向贇, 马群宝, 莫亚斯尔·热合木拉, 黄玉蓉. 抗血管生成药物联合PD-1单抗治疗NSCLC的疗效及对T淋巴细胞亚群的影响[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(04): 510-515.
[6] 徐倩, 魏凤香. 干细胞:开启精神疾病治疗的新曙光[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(01): 52-55.
[7] 张婷, 张延美, 范皎, 卜玉, 张莉. 负载R848疏水性介孔二氧化硅纳米粒的制备及复极化巨噬细胞的研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2025, 15(06): 339-345.
[8] 刘沐芸, 侯凯翔, 韩奇鹏, 崔诗慧, 魏殿华, 符业优, 丁关焱, 从丽萍, 梁晓, 安刚. 脂肪与骨髓间充质干细胞的免疫调节作用及协同治疗潜力分析[J/OL]. 中华细胞与干细胞杂志(电子版), 2025, 15(04): 220-228.
[9] 刘铁鑫, 王震侠. 肿瘤相关成纤维细胞在胰腺导管腺癌中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 124-131.
[10] 唐孝丽, 张正筠, 周尊强. 重视肝脏囊性病变的诊治[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 366-371.
[11] 阿里木江·马木提, 吐尔洪江·吐逊. 肝泡型棘球蚴病外科治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 475-480.
[12] 姜波, 尤伟艳, 薛庆, 赵长甲, 张琪, 任珊. 骆驼乳清蛋白在脓毒症辅助治疗中的应用前景[J/OL]. 中华重症医学电子杂志, 2025, 11(04): 407-411.
[13] 崔滨, 王丹慧, 王林, 陈国强. Treg细胞在神经病理性疼痛中的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2025, 15(05): 303-308.
[14] 李艳, 呼霞, 赵娟. 超声引导下腰方肌阻滞与竖脊肌平面阻滞对腹腔镜结直肠癌根治术后应激指标、炎症因子、T淋巴细胞亚群的影响[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(04): 393-397.
[15] 刘文倩, 王伊龙. 颅骨骨髓在中枢神经系统中的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(01): 9-15.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?